相关实验视频
Updated: Sep 12, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
脂蛋白 (a) 在初级心血管疾病预防中是今天可以采取行动的
Vibhu Parcha1, Vera A Bittner1
1Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, United States of America.
脂蛋白 (Lp) 是心血管疾病的关键遗传风险因素. 早期的Lp (a) 测试可以改善风险评估,并指导心脏病学中的预防策略.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 预防医学 预防医学
背景情况:
- 脂蛋白 (Lp) 是动脉样硬化心血管疾病 (ASCVD) 和动脉疾病的遗传决定性风险因素.
- 它在心血管疾病和死亡率中的因果作用越来越被认可,但其在初级预防中的实用性被低估了.
研究的目的:
- 审查早期Lp (a) 测量的科学基础.
- 为了阐明Lp的病原性机制.
- 评估治疗选择,并提出一个临床框架,以整合Lp (a) 检测到初级预防中.
主要方法:
- 评论当代科学文献.
- 临床数据和图片的分析.
- 对Lp(a) 相关风险的不断变化的治疗环境的评估.
主要成果:
- 升高的Lp(a) 水平可以显著影响心血管风险重新分类.
- (一) 鉴定有助于加强可修改的风险因素的管理.
- 测试为以患者为中心的预防策略提供了可操作的见解.
结论:
- 在当代初级预防中,早期测量脂蛋白是可行的.
- 将Lp (a) 测试纳入临床实践可以增强心血管疾病预防策略.
- 识别升高的Lp (a) 支持个性化风险管理和患者护理.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
相关概念视频
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Atherosclerosis I: Introduction